No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Express News | Amphastar Pharmaceuticals Inc : BofA Global Research Cuts Price Objective to $46 From $55
These 4 Measures Indicate That Amphastar Pharmaceuticals (NASDAQ:AMPH) Is Using Debt Reasonably Well
Top U.S. Health Care Mid-cap Stocks and Their Quant Ratings
Little Excitement Around Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Earnings
Amphastar Pharmaceuticals Insiders Sold US$975k Of Shares Suggesting Hesitancy